Work

The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision

Year: 2026
Type: article
Abstract: Background and Objectives: This study aimed to evaluate the effect of a topical anaesthetic gel versus subconjunctival anaesthesia on peri- and postoperative pain and on postoperative ocular discomfort in patients undergoing pterygium surgery. Materials and Methods: This prospective, randomised, patient- and investigator-masked clinical trial included 41 patients undergoing primary pterygium excision. Patients were randomly assigned to two groups (A and B) matched in terms of gender, pterygium size, and age. Group A patients received 2% lidocaine gel, while Group B patients received a subconjunctival injection of xylocaine 2% hydrochloride solution with 0.125 epinephrine (12.5 µg/mL). Peri- and postoperative pain was measured using the Visual Analogue Scale (VAS), and ocular discomfort was evaluated on postoperative days 1 and 8 using the Ocular Surface Disease Index (OSDI) and the Oxford Dry Eye Scale. Results: There was no statistically significant difference between groups in terms of peri- and postoperative pain, neither for average nor for decrease in average VAS scores (all p > 0.05). Postoperative Oxford Dry Eye Scale scores did not differ significantly between groups (all p > 0.05). Although overall lower OSDI scores were measured for the lidocaine group on postoperative days 1 and 8 (39.4 ± 28.6 vs. 48.1 ± 25.6 and 23.5 ± 14.0 vs. 28.2 ± 17.5, respectively), this result was not statistically significant (p = 0.311 and p = 0.349, respectively). Conclusions: Topical lidocaine gel can be an effective and safe alternative to the traditional subconjunctival xylocaine injection for pterygium excision. It is easy to administer, may reduce the need for frequent ocular surface lubrication, and provides comparable pain control during surgery. However, our study shows that topical lidocaine gel does not offer significant postoperative advantages in terms of pain, dryness, or irritation.
Source: Medicina
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,654
Funder: Horus Pharma
OpenAlex ID: W7165478025
FWCI:
Cites: 30
Cited by:
Related to: 10